Author: Bill Snyder
Sep. 27, 2018—Reining in the nation’s opioid epidemic will require diverse and innovative strategies ranging from drug discovery to “policy translation,” according to speakers at a recent Vanderbilt Faculty Cutting-edge Discovery Lecture.
Sep. 6, 2018—Innovative strategies for addressing the nation’s opioid epidemic and its consequences will be discussed during a Cutting-edge Discovery Lecture on Sept. 13. The lecture will begin at 4 p.m. in room 208 Light Hall.
Sep. 6, 2018—Vanderbilt University School of Medicine welcomed 112 new doctoral students on Aug. 31 during the ninth annual Simple Beginnings ceremony in a Light Hall lecture room filled with family members and other well-wishers.
Sep. 6, 2018—An international research team including scientists from Vanderbilt University has discovered how the diabetes drug metformin blocks glucose production by the liver. The discovery, reported Aug. 27 in the journal Nature Medicine, could lead to development of new ways to treat type 2 diabetes.
Aug. 30, 2018—Researchers at Vanderbilt University Medical Center have isolated the first human monoclonal antibodies that can neutralize norovirus, the leading cause of acute gastrointestinal illness in the world.
Aug. 23, 2018—Researchers at Vanderbilt University and the University of Michigan have discovered a critical factor in the rheostatic control of body weight by the brain.
Aug. 23, 2018—The Vanderbilt University School of Medicine has established a new award to recognize and support outstanding graduate students who have distinguished themselves through the excellence, significance and scientific rigor of their work.
Aug. 9, 2018—Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation.